10-Q: Ethema Health Corporation Reports Q3 2024 Results, Revenue Up 30% But Operating Loss Widens
Quarterly Report
Ethema Health Corporation's Q3 2024 results show a 30% increase in revenue compared to the same period last year, but also a significant increase in operating expenses leading to an operating loss.
Summary
- Ethema Health Corporation reported a revenue of $1.76 million for the three months ended September 30, 2024, a 30% increase compared to $1.35 million in the same period of 2023.
- Operating expenses increased by 88.1% to $2.48 million, up from $1.32 million in the prior year, driven by higher rent, management fees, and salaries.
- The company experienced an operating loss of $723,708 for the quarter, compared to an operating income of $33,528 in Q3 2023.
- Net loss for the quarter was $1.00 million, a significant decrease from the net income of $2.11 million in the same quarter of the previous year.
- For the nine months ended September 30, 2024, revenue was $4.55 million, a 7.8% increase from $4.22 million in the same period of 2023.
- Operating expenses for the nine-month period increased by 41.7% to $5.78 million, up from $4.08 million in the prior year.
- The company reported an operating loss of $1.23 million for the nine-month period, compared to an operating income of $140,700 in the same period of 2023.
- Net loss for the nine-month period was $1.84 million, a decrease from the net income of $1.70 million in the same period of the previous year.
- The company's working capital deficiency is $7.1 million, with total liabilities exceeding assets by the same amount, raising concerns about its ability to continue as a going concern.
Sentiment
Score: 3
Explanation: The document presents a mixed picture with strong revenue growth offset by significant increases in operating expenses and a substantial net loss. The going concern warning and reliance on external funding contribute to a negative sentiment.
Positives
- Revenue increased by 30% in Q3 2024 compared to Q3 2023, indicating growth in the company's core business.
- The company's revenue from in-patient services increased by 12.8% for the nine months ended September 30, 2024.
- The company has stabilized the Edgewater Recovery operations and it is now cash flow positive.
- The company plans to add 16 beds at the Paducah location, which is currently operating at full capacity.
Negatives
- Operating expenses increased significantly, by 88.1% in Q3 2024, outpacing revenue growth.
- The company experienced an operating loss of $723,708 in Q3 2024, a sharp decline from the operating income in the same period last year.
- Net loss for Q3 2024 was $1.00 million, a significant decrease from the net income of $2.11 million in Q3 2023.
- The company's working capital deficiency is $7.1 million, and total liabilities exceed assets by the same amount.
- The company's auditors have raised concerns about its ability to continue as a going concern.
Risks
- The company's significant working capital deficiency and excess of liabilities over assets raise substantial doubt about its ability to continue as a going concern.
- The company is dependent on raising additional capital through equity or debt financing, which may not be successful.
- Increased operating expenses, particularly in rent and management fees, are impacting profitability.
- The company faces liquidity risk due to its financial position and reliance on external funding.
- The company's disclosure controls and procedures are not effective due to a lack of written policies and procedures.
Future Outlook
The company plans to continue growing the Evernia business organically or through acquisitions, and expects to increase patient numbers at its Kentucky facility. The company estimates it will require approximately $3.5 million for working capital and to repay existing short-term notes over the next twelve months.
Management Comments
- The Ethema management team has stabilized the ETC operations over the last three months and is cash flow positive.
- We intend to add another 16 beds in October at the Paducah location, which has been operating at full capacity, increasing revenue in this underserved market.
Industry Context
The company operates in the addiction treatment industry, which is experiencing increased demand. The company's expansion into Kentucky is a strategic move to capitalize on this demand, particularly in the Medicaid market. The ongoing investigations into other Medicaid providers in Kentucky may present an opportunity for Ethema to expand its footprint.
Comparison to Industry Standards
- The company's revenue growth of 30% in Q3 2024 is a positive sign, but the significant increase in operating expenses is a concern.
- Compared to other healthcare providers, Ethema's operating loss and net loss are significant and need to be addressed.
- The company's working capital deficiency and going concern issues are not typical for established healthcare providers and indicate a need for immediate financial restructuring.
- The company's reliance on short-term debt and related party transactions is higher than industry standards, indicating a need for more sustainable financing strategies.
- The company's expansion into Kentucky is a positive move, but the success of this expansion will depend on its ability to manage costs and secure necessary licenses and contracts.
Related Party Transactions
- The company has significant related party payables to Shawn E. Leon and Eileen Greene.
- Shawn E. Leon was credited with a management fee of $480,000 during the current quarter.
- Mr. Leon converted $1,500,000 of related party payable into common stock.
- Ms. Greene converted $500,000 of related party payable into common stock.
- Ms. Greene advanced the company $250,000 with an original issue discount of $35,000.
- The company issued 600,000 shares of Series A Preferred stock to Mr. Shawn Leon for the conversion of $6,000 of related party payables.
Stakeholder Impact
- Shareholders face potential dilution from future equity raises.
- Employees may be impacted by the company's financial instability.
- Customers may be affected by any changes in service delivery due to financial constraints.
- Creditors face increased risk due to the company's high debt levels and going concern issues.
- Suppliers may be impacted by the company's ability to pay its obligations.
Next Steps
- The company plans to continue to grow the Evernia business organically or through acquisitions.
- The company plans to add 16 beds at the Paducah location in October.
- The company will continue to manage the Edgewater Recovery operations until ARIA Kentucky is fully licensed and contracted.
- The company will need to secure additional financing to address its working capital deficiency and repay existing debt.
Key Dates
| Date | Description |
|---|---|
| 2010 | The Company began operating addiction treatment centers. |
| 2016-12 | The Company obtained a license to operate an addiction treatment center in Delray Beach, Florida. |
| 2017-02-14 | The Company sold its Greenestone Muskoka clinic in Ontario, Canada. |
| 2019-02-01 | ATHI entered into an operating lease agreement for property at 950 Evernia Street, West Palm Beach, Florida. |
| 2019-04-12 | The Company entered into a secured promissory note with LXT Biotech. |
| 2020-06-30 | The Company became actively involved in the management of a treatment center operated by Evernia in West Palm Beach, Florida. |
| 2020-07-12 | The Company entered into a five-year option agreement with Leonite Capital LLC. |
| 2020-09-14 | The Company entered into a five-year option agreement with Ed Blasiak. |
| 2020-10-29 | The Company entered into a five-year option agreement with First Fire and Bauman. |
| 2021-05-03 | ARIA was granted a government assistance loan. |
| 2021-07-01 | The Company closed on the acquisition of 75% of ATHI. |
| 2021-10 | The lease for 950 Evernia Street was extended for a further 5 years. |
| 2022-09-21 | ARIA received partial forgiveness of the government assistance loan. |
| 2022-10-03 | The Company entered into a purchase and sale agreement for 950 Evernia Street. |
| 2023-06-02 | The Company entered into a Receivables Sale Agreement with Bizfund.com. |
| 2023-06-30 | The Company disposed of Cranberry Cove Holdings (CCH). |
| 2023-08-03 | The Company closed on the acquisition of the property at 950 Evernia Street. |
| 2023-08-04 | The Company entered into a long-term lease for 950 Evernia Street. |
| 2023-09-15 | The Company entered into a Receivables Sale Agreement with Itria Ventures LLC. |
| 2023-11-15 | The Company entered into a senior secured promissory note with Mirage Realty, LLC. |
| 2024-02-01 | Ethema Health Corporation entered into a secured revolving line of credit agreement with Testing 123, LLC. |
| 2024-03-22 | The Company executed a LOI to acquire assets of Boca Cove Detox, LLC. |
| 2024-04-15 | The Company entered into securities purchase agreements for Series R promissory notes. |
| 2024-05-01 | The Company entered into a Definitive Agreement to assume the lease for the Boca Raton facility. |
| 2024-05-15 | The Company entered into a Stock Purchase Agreement to acquire the remaining 25% of ATHI. |
| 2024-05-29 | The Company entered into a Receivables Sale Agreement with Fortunate Sons. |
| 2024-06-10 | The lease for the Boca Raton facility was assigned to the Company. |
| 2024-07-08 | The Company finalized the execution of a letter of intent with Edgewater Recovery Center LLC. |
| 2024-07-12 | Mr. Leon converted $1,500,000 of related party payable into common stock and Ms. Greene converted $500,000 of related party payable into common stock. |
| 2024-08-30 | The Company entered into a Receivables Sale Agreement with Itria Ventures LLC. |
| 2024-09-27 | The Company issued 600,000 shares of Series A Preferred stock to Mr. Shawn Leon. |
| 2024-09-30 | End of the reporting period for the quarterly report. |
| 2024-10-22 | ARIA Kentucky, LLC entered into a binding Asset Purchase Agreement to acquire the business of ETC. |
| 2024-11-14 | Date of the quarterly report. |
Keywords
Ethema Health Corporation, addiction treatment, rehabilitation services, financial results, quarterly report, operating loss, revenue growth, going concern, debt financing, working capital
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.